Search Results 951-960 of 24157 for B cell lymphomas

  1. Transplant Medicine Physicians - Medical Professionals - Mayo Clinic

    CAR-T cell therapy, Bone marrow transplant, Lymphoma, Follicular lymphoma, B-cell lymphoma · Mauricio A. Villavicencio ...

  2. Hematology - Doctors - Mayo Clinic

    Bone marrow transplant, CAR-T cell therapy, Myelodysplastic syndromes, B-cell lymphoma, Lymphoma, Follicular lymphoma, ...Leukemia. Show more areas of focus ...

  3. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C - Mayo Clinic

    To assess the proportion of individuals with MBL who have an improvement in the circulating monoclonal B-cell population following therapy with DAA ...

  4. Hematology - Clinical trials

    ... B-cell non-Hodgkin lymphoma (NHL) who have received at least two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module 2 for DLBCL ...

  5. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    Patients to be included in Cohorts 1 and 4, and who have received rituximab or other B cell ablation therapy within 8 weeks of start of study treatment. 7 ...

  6. Transplant Medicine Physicians - Medical Professionals - Mayo Clinic

    Bone marrow transplant, CAR-T cell therapy, B-cell lymphoma, Lymphoma, Burkitt lymphoma, Follicular lymphoma, Hodgkin lymphoma ...

  7. Clinical trials - Oncology (Medical)

    ... b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial ...

  8. A Study To Evaluate Acalabrutinib With Or Without Obinutuzumab To Treat Early-Stage Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    ... cell population in the peripheral blood with immunophenotyping consistent with CLL as follows: The population of lymphocytes share both B-cell antigens ...

  9. A Study to Evaluate CTX110 in Subjects with Relapsed or Refractory B-Cell Malignancies - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness CTX110 in subjects with relapsed or refractory B cell malignancies. Participation ...

  10. Medical Research & Education - Mayo Clinic News Network

    ... B-Cell Lymphoma featured image. Cancer. Everolimus R-CHOP Combination Safe for Treating Diffuse Large B-Cell Lymphoma. Joe Dangor. June 29, 2016. In the Loop ...